215 related articles for article (PubMed ID: 10807559)
1. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
Clewell HJ; Gentry PR; Covington TR; Gearhart JM
Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):283-305. PubMed ID: 10807559
[TBL] [Abstract][Full Text] [Related]
2. Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.
Lash LH; Chiu WA; Guyton KZ; Rusyn I
Mutat Res Rev Mutat Res; 2014; 762():22-36. PubMed ID: 25484616
[TBL] [Abstract][Full Text] [Related]
3. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action.
Bogen KT; Benson JM; Yost GS; Morris JB; Dahl AR; Clewell HJ; Krishnan K; Omiecinski CJ
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S27-36. PubMed ID: 18191315
[TBL] [Abstract][Full Text] [Related]
4. Can the observed association between serum perfluoroalkyl substances and delayed menarche be explained on the basis of puberty-related changes in physiology and pharmacokinetics?
Wu H; Yoon M; Verner MA; Xue J; Luo M; Andersen ME; Longnecker MP; Clewell HJ
Environ Int; 2015 Sep; 82():61-8. PubMed ID: 26043300
[TBL] [Abstract][Full Text] [Related]
5. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.
Najjar A; Punt A; Wambaugh J; Paini A; Ellison C; Fragki S; Bianchi E; Zhang F; Westerhout J; Mueller D; Li H; Shi Q; Gant TW; Botham P; Bars R; Piersma A; van Ravenzwaay B; Kramer NI
Arch Toxicol; 2022 Dec; 96(12):3407-3419. PubMed ID: 36063173
[TBL] [Abstract][Full Text] [Related]
6. Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values.
Chou WC; Lin Z
Environ Health Perspect; 2021 Mar; 129(3):37004. PubMed ID: 33730865
[TBL] [Abstract][Full Text] [Related]
7. Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy.
George B; Lumen A; Nguyen C; Wesley B; Wang J; Beitz J; Crentsil V
NPJ Syst Biol Appl; 2020 Nov; 6(1):36. PubMed ID: 33159093
[TBL] [Abstract][Full Text] [Related]
8. Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.
Yang X; Duan J; Fisher J
PLoS One; 2016; 11(10):e0164641. PubMed ID: 27723791
[TBL] [Abstract][Full Text] [Related]
9. Lipid dynamics in zebrafish embryonic development observed by DESI-MS imaging and nanoelectrospray-MS.
Pirro V; Guffey SC; Sepúlveda MS; Mahapatra CT; Ferreira CR; Jarmusch AK; Cooks RG
Mol Biosyst; 2016 Jun; 12(7):2069-79. PubMed ID: 27120110
[TBL] [Abstract][Full Text] [Related]
10. Studying permethrin exposure in flight attendants using a physiologically based pharmacokinetic model.
Wei B; Isukapalli SS; Weisel CP
J Expo Sci Environ Epidemiol; 2013 Jul; 23(4):416-27. PubMed ID: 23462847
[TBL] [Abstract][Full Text] [Related]
11. Human health effects of trichloroethylene: key findings and scientific issues.
Chiu WA; Jinot J; Scott CS; Makris SL; Cooper GS; Dzubow RC; Bale AS; Evans MV; Guyton KZ; Keshava N; Lipscomb JC; Barone S; Fox JF; Gwinn MR; Schaum J; Caldwell JC
Environ Health Perspect; 2013 Mar; 121(3):303-11. PubMed ID: 23249866
[TBL] [Abstract][Full Text] [Related]
12. Application of physiologically based pharmacokinetic models in chemical risk assessment.
Mumtaz M; Fisher J; Blount B; Ruiz P
J Toxicol; 2012; 2012():904603. PubMed ID: 22523493
[TBL] [Abstract][Full Text] [Related]
13. Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants.
Ruiz P; Ray M; Fisher J; Mumtaz M
Int J Mol Sci; 2011; 12(11):7469-80. PubMed ID: 22174611
[TBL] [Abstract][Full Text] [Related]
14. Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).
Mumtaz MM; Ray M; Crowell SR; Keys D; Fisher J; Ruiz P
J Toxicol Environ Health A; 2012; 75(1):6-24. PubMed ID: 22047160
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development.
Khalil F; Läer S
J Biomed Biotechnol; 2011; 2011():907461. PubMed ID: 21716673
[TBL] [Abstract][Full Text] [Related]
16. An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants.
Valcke M; Krishnan K
Int J Environ Res Public Health; 2010 Nov; 7(11):4002-22. PubMed ID: 21139873
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.
Matthews JL; Schultz IR; Easterling MR; Melnick RL
Toxicol Appl Pharmacol; 2010 Apr; 244(2):196-207. PubMed ID: 20045428
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian population PBPK model for multiroute chloroform exposure.
Yang Y; Xu X; Georgopoulos PG
J Expo Sci Environ Epidemiol; 2010 Jun; 20(4):326-41. PubMed ID: 19471319
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.
Kim S; Kim D; Pollack GM; Collins LB; Rusyn I
Toxicol Appl Pharmacol; 2009 Jul; 238(1):90-9. PubMed ID: 19409406
[TBL] [Abstract][Full Text] [Related]
20. Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies.
Melnick RL; Thayer KA; Bucher JR
Environ Health Perspect; 2008 Jan; 116(1):130-5. PubMed ID: 18197312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
